respiratory disease poses enormous burden individuals society asthma chronic obstructive pulmonary disease copd diseases discussed contribute substantial proportion ill health cost nhs economy health professionals consider inhaled route best method delivering drugs respiratory types inhaled delivery use pressurised metered dose inhalers pmdis dry powder devices pmdis large volume spacers combination nebulisers uk pmdis cheapest type device market usually method choice patients able use international agreement phase cfcs led development alternative propellants pmdis role pmdis predicted increase future demand pmdis treat asthma likely increase introduction clinical guidelines extends best practice use treat patients copd increasing novel drugs respiratory including gene therapy drugs disorders employ pmdis delivery future non respiratory